Sept. 6, 2024 - 3rd Annual GU Cancer Symposium - Advances in Bladder Cancers

Fairfax, VA US
September 6, 2024

Program Description

Bladder cancer makes up about 4% of cancers in the US. It is the fourth most common cancer in men, but it’s less common in women. Join us for a FREE half-day, in-person event and understand the latest treatment options, diagnostic tests, imaging, and multidisciplinary treatment of non-muscle invasive bladder cancer, muscle-invasive bladder cancer, and metastatic urothelial cancer. The education will foster collaborative efforts amongst Inova physicians, APPs, nurses, and allied health professionals.

 

In-Person Only

This event is being offered as an in-person conference only.  There will be no virtual piece or recorded sessions.  Attendees will have the opportunity to join the speakers in-person at Inova Center for Personalized Health Conference Center (ICPH) .  

 

Questions & Refunds

Refunds will be allowed up to five days before the conference, September 1, 2024. Refund requests need to be submitted in writing to Christina.fontana@inova.org

If at any time you have questions, please email: Christina.fontana@inova.org

Target Audience

  • Advanced Practice Providers
  • Dietitians
  • Family Medicine
  • Genetic Counselors
  • Internists
  • Medical Oncologists
  • Nurses
  • Nurse Navigators
  • Physicians
  • Radiation Oncologists
  • Radiologists
  • Therapists
  • Urologists
  • Urologic Oncologists
  • Residents, Students, and Fellows
  • Other Allied Health professionals and Trainees

Learning Objectives

  • Summarize the VIRADS system for diagnosing bladder tumors.
  • Indicate the state-of-the-art treatments with intravesical therapies in non-muscle-invasive bladder cancers (NMIBC).
  • Identify bladder preservation in muscle-invasive bladder cancer (MIBC).
  • Determine the role of genomics and implications in diagnosis and treatment in urothelial cancers.
  • Obtain updates in systemic therapy applications in muscle-invasive bladder cancer especially with adjuvant therapy and the changing landscape of metastatic urothelial cancer treatment.

 

Questions about this event?  Contact Christina.Fontana@inova.org. 

Course summary
Available credit: 
  • 3.50 ABS MOC
  • 3.50 AMA PRA Category 1 Credit™
Course opens: 
06/17/2024
Course expires: 
12/31/2024
Event starts: 
09/06/2024 - 7:00am EDT
Event ends: 
09/06/2024 - 11:45am EDT
Cost:
$0.01
Add to calendar: 
Rating: 
5

3rd Annual GU Cancer – Advances in Bladder Cancer

September 6, 2024 | In-Person Only | ICPH

Presentation

Speaker

Time

Breakfast with Exhibitors and Registration

Atrium

7:00 – 7:30 a.m.

Welcome Remarks

J. Stephen Jones, MD, MBA, FACS

Inova Health System

7:30 – 7:45 a.m.

MRI and CT Characteristics of Bladder Cancer (VI-RADS)

J. Cullen Ruff, MD, FACR

Inova Health System

7:45 – 8:05 a.m.

Management of Non-muscle Invasive Bladder Cancers

Adam R. Metwalli, MD

Thomas Jefferson University Hospital

8:05 – 8:30 a.m.

Management of MIBC Bladder Preservation Strategy

Daniel Kim, MD

Inova Health System

8:30 – 8:55 a.m.

Role of Adjuvant Therapy in MIBC

Andrea Apolo, MD

Genitourinary Malignancies Branch, NCI/CCR

8:55 – 9:25 a.m.

Multidisciplinary Treatment of Localized, Locally Advanced MIBC

Moderator: Inger Lerra Rosner, MD

Inova Health System

 

Panelists: Adam R. Metwalli, MD, Andrea Apolo, MD, Daniel Kim, MD, J. Cullen Ruff, MD, FACR

9:25 – 9:55 a.m.

Break with Exhibitors

Atrium

9:55 – 10:15 a.m.

Treatment of Metastatic Urothelial Cancer

Andrea Apolo, MD

Genitourinary Malignancies Branch, NCI/CCR

10:15 – 10:40 a.m.

Multidisciplinary Treatment Approach for Advanced and Metastatic Urothelial Cancer

Moderator: Jeanny B. Aragon-Ching, MD, FACP

Inova Health System

 

Panelists: Eunmi Yu, MD, Joshua M. Allen, MD, Andrea Apolo, MD, Inger Lerra Rosner, MD

10:40 – 11:10 a.m.

Keynote: Bladder Cancer - Evolution of Genomics and Impact on Management

David J. McConkey PhD

Johns Hopkins Greenberg Bladder Cancer Institute & Johns Hopkins School of Medicine

11:10 – 11:40 a.m.

Closing Remarks

Jeanny B. Aragon-Ching, MD, FACP

Inova Health System

11:45 a.m.

Inova Center for Personalized Health Conference Center (ICPH)
8100 Innovation Park Drive
2nd Level
Fairfax, VA 22301
United States

Parking

Parking is complimentary at the Inova Center for Personalized Health Conference Center (ICPH) . Park in any Surface Lots.  Use Entrance 3 under the pedestrian bridge to enter the Conference Center and take stairs or elevator to level 2. 

Travel

Airports and Ground Transportation

Inova Center for Personalized Health Conference Center (ICPH)  is centrally located between Washington Dulles Airport (IAD) and Reagan Airports (DCA).  Union Station (in Washington, DC) is located about 30-40 minutes from the campus.  Both airports along with Union Station offer onsite ground transportation to Fairfax, VA which is about a 30–40-minute drive.  Uber or Lyft are also reliable ground transportation options in the DC metro area.

Hotels

Below are the two hotels that are located closest to the Inova Center for Personalized Health Conference Center (ICPH) and offer us discounted rates.

8296 Glass Alley, Fairfax, VA 22031

Phone: 571-327-2277

Inova/corporate rate code: 8296INOVA

 

3111 Fairview Park Dr, Falls Church, VA 22042

(703) 849-9400

    Program Directors:

    Jeanny B. Aragon-Ching, MD, FACP

    Clinical Program Director of Genitourinary Cancers,
    Inova Schar Cancer Institute
    Associate Professor of Medical Education,
    University of Virginia School of Medicine, Inova Campus

    Daniel W. Kim, MD, MBA

    Director, Genitourinary Radiation Oncology
    Inova Schar Cancer Institute
    Department of Advanced Radiation Oncology and Proton Therapy

     

    Inger L. Rosner, MD

    Schar Chair for Urologic Oncology
    System Section Chief, Urology
    Inova Schar Cancer Institute/Inova Fairfax Hospital
    Associate Professor of Medical Education, University of
    Virginia School of Medicine, Inova Campus

     

    Speaker Disclosure Statement:

    Inova Health System’s Office of Continuing Medical Education adheres to ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, program directors, and planners are required to disclose all relevant financial relationships with ineligible entities as defined by ACCME.  All relevant financial relationships listed for these individuals have been mitigated.  

    Program Director(s)

    Jeanny Aragon-ching

    has a financial relationship (Professional Services) with Bristol Myers Squibb;.
    has a financial relationship (Consulting Fee) with Pfizer/EMD Serono;.
    has a financial relationship (Consulting Fee) with Exelixis ;.
    has a financial relationship (Consulting Fee) with Immunomedics;.
    has a financial relationship (Consulting Fee) with AZD;.
    has a financial relationship (Consulting Fee) with Bayer;.
    has a financial relationship (Consulting Fee) with Pfizer/Myovant;.
    has a financial relationship (Professional Services) with Astellas/Seattle Genetics;.
    has a financial relationship (Consulting Fee) with Merck;.
    has a financial relationship (Consulting Fee) with AVEO;.

    Daniel Kim, MD, MBA

    has no relevant financial relationships to disclose at this time.

    Inger Rosner, MD

    has no relevant financial relationships to disclose at this time.
    Speaker(s)

    Joshua Allen

    has no relevant financial relationships to disclose at this time.

    Andrea Apolo, MD

    has no relevant financial relationships to disclose at this time.

    Jeanny Aragon-ching

    has a financial relationship (Consulting Fee) with Pfizer/Myovant;.
    has a financial relationship (Consulting Fee) with Bayer;.
    has a financial relationship (Consulting Fee) with Merck;.
    has a financial relationship (Consulting Fee) with AVEO;.
    has a financial relationship (Professional Services) with Astellas/Seattle Genetics;.
    has a financial relationship (Consulting Fee) with Pfizer/EMD Serono;.
    has a financial relationship (Consulting Fee) with Exelixis ;.
    has a financial relationship (Professional Services) with Bristol Myers Squibb;.
    has a financial relationship (Consulting Fee) with Immunomedics;.
    has a financial relationship (Consulting Fee) with AZD;.

    Daniel Kim, MD, MBA

    has no relevant financial relationships to disclose at this time.

    David McConkey, PhD

    has a financial relationship (Consulting Fee) with CG Oncology;.
    has a financial relationship (Other) with Convergent Genomics;.
    has a financial relationship (Grant Or Contract) with Janssen;.

    Adam Metwalli, MD

    has no relevant financial relationships to disclose at this time.

    Inger Rosner, MD

    has no relevant financial relationships to disclose at this time.

    Eunmi Yu

    has no relevant financial relationships to disclose at this time.

    Inova CME Accreditation

    The Medical Society of Virginia is a member of the Southern States CME Collaborative, an ACCME Recognized Accreditor. Inova Health System Office of Continuing Medical Education is accredited by the Southern States CME Collaborative to provide continuing medical education for physicians.

    Credit Designation

    The Inova Office of Continuing Medical Education designates this live educational activity for a maximum of 3.5 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physicians may claim up to 3.5 credits in Type 1 CME on the Virginia Board of Medicine Continued Competency and Assessment Form required for renewal of an active medical license in Virginia.

     

    ABS CC Statement

    Successful completion of this CME activity enables the learner to earn credit toward the CME requirement(s) of the American Board of Surgery's Continuous Certification program. It is the CME activity provider's responsibility to submit to ACCME for the purpose of granting ABS credit.

     

    Nurse Credentialing FAQs

    For the purpose of recertification, the American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME.  For more information visit, https://www.nursingworld.org/certification/faqs/

    Available Credit

    • 3.50 ABS MOC
    • 3.50 AMA PRA Category 1 Credit™

    Thank you Exhibitors! Our event would not be possible without the generous support from our sponsors.

     

    • Astellas Pharma US
    • AstraZeneca
    • Bristol Myers Squibb
    • Exelixis
    • Inova Peterson Life with Cancer
    • Johnson and Johnson Innovative Medicine Oncology
    • Merck
    • Novartis
    • Pfizer Oncology
    • Tempus AI

     

    Exhibit Packages
    General Exhibit Table: $1,500

    • 6' undraped table with two chairs
    • Opportunity to interact with attendees during registration, meals, and all breaks
    • Full access to conference sessions and breakfast for two exhibit representatives
    • Company name listed on opening and break slides and event signage
    • Company name recognition on:
      • Marketing emails
      • Introduction slides, break slides, and closing slides
      • Welcome email to all registered attendees
      • Post-event follow up attendee email
      • Exhibitor page on event website

     

    Premium Exhibitor Table: $2,000

     

    • 6' undraped table with two chairs
    • Opportunity to interact with attendees during registration, meals, and all breaks
    • Full access to conference sessions and breakfast for two exhibit representatives
    • Verbally recognized during event opening and closing
    • Company name listed on opening and break slides and event signage
    • Post attendee registration list
    • Company name recognition on:
      • Marketing emails
      • Introduction slides, break slides, and closing slides
      • Welcome email to all registered attendees
      • Post-event follow up attendee email
      • Exhibitor page on event website


    Nonprofit Organizations Table - $500 (501c3 must be submitted for approval)

     

    • 6' undraped table with two chairs
    • Opportunity to interact with attendees during registration, meals, and all breaks
    • Full access to conference sessions and breakfast for two exhibit representatives
    • Company name listed on opening and break slides and event signage
    • Company name recognition on:
      • Marketing emails
      • Introduction slides, break slides, and closing slides
      • Welcome email to all registered attendees
      • Post-event follow up attendee email
      • Exhibitor page on event website

    Download the full prospectus here: PDF icon GU Cancer 090624 PROSPECTUS.pdf

    Questions? Email Christina Fontana for more information. 

     

    Price

    Cost:
    $0.01
    Please login or register to take this course.

    Registration Information:

    In order to view all the event information, please sign in or create an account. 

     

    Are you an Inova Employee?

    You can register via cost center.

    Once receiving approval from your department leader, enter your cost center into the ‘coupon’ field while registering (or checking out).  If it doesn’t apply, please email Christina.Fontana@inova.org for additional assistance. Your sponsoring department will be charged the cost of registration after the event.

     

    Refunds:

    Refunds will be allowed up a to week before the event, September 1, 2024 . Refund requests need to be submitted in writing to CME@inova.org.